AI tool for melanoma diagnosis during skin checks
Part of Cancer, Skin clinical trials.
This study tests an artificial intelligence (AI) tool that helps doctors spot melanoma and other skin conditions during your regular skin check. The tool is meant to help with diagnosis for people with moles, new growths, or a history of skin cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have an in-person visit with a dermatologist at a participating clinic
- The visit is for a skin check, a suspicious mole, or a history of skin cancer
- The clinic has trained its doctors to use the AI tool
- Your images have not been used to train or test the AI tool before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a telemedicine tool can help find skin tumors early. It may be a good fit if you have a suspicious spot and light skin that burns easily.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.
This study is testing a computer program that uses photos of your moles to help doctors find skin cancer (melanoma) earlier. If you have many moles, joining could help improve this technology for everyone.
This study uses artificial intelligence to help detect melanoma (a type of skin cancer) and predict risk in children, teens, and young adults. Researchers want to see if AI can spot melanoma early and assess risk better.
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
Hear when a new Hemangioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.